Yuki Asano‐Mori

Cytomegalovirus Reactivation after Allogeneic Hematopoietic Stem Cell Transplantation is Associated with a Reduced Risk of Relapse in Patients with Acute Myeloid Leukemia Who Survived to Day 100 after Transplantation: The Japan Society for Hematopoietic Cell Transplantation Transplantation-related Complication Working Group

Katsuto Takenaka, Tetsuya Nishida, Yuki Asano‐Mori et al. · Biology of Blood and Marrow Transplantation · 2015 · 190 citations · Full text

Cell Therapy, Transplantation Medicine, Immunology +18

Long‐term ultra‐low‐dose acyclovir against varicella‐zoster virus reactivation after allogeneic hematopoietic stem cell transplantation

Yuki Asano‐Mori, Yoshinobu Kanda, Kumi Oshima et al. · American Journal of Hematology · 2008 · 79 citations · Full text

False-positive Aspergillus galactomannan antigenaemia after haematopoietic stem cell transplantation

Yuki Asano‐Mori, Yoshinobu Kanda, Koichi Oshima et al. · Journal of Antimicrobial Chemotherapy · 2007 · 74 citations · Full text

A Novel Reduced-Toxicity Myeloablative Conditioning Regimen Using Full-Dose Busulfan, Fludarabine, and Melphalan for Single Cord Blood Transplantation Provides Durable Engraftment and Remission in Nonremission Myeloid Malignancies

Hisashi Yamamoto, Naoyuki Uchida, Mitsuhiro Yuasa et al. · Biology of Blood and Marrow Transplantation · 2016 · 66 citations · Full text

In Vivo Alemtuzumab Enables Haploidentical Human Leukocyte Antigen-Mismatched Hematopoietic Stem-Cell Transplantation Without Ex Vivo Graft Manipulation

Yoshinobu Kanda, Kumi Oshima, Yuki Asano‐Mori et al. · Transplantation · 2005 · 63 citations